Lakewood-Amedex Biotherapeutics Inc. (LABT) Live Share Price, Invest From India

Lakewood-Amedex Biotherapeutics Inc. Stock Performance

as on October 26, 2026 at 2:16 pm IST

Day's Low
Day's High
$0.28
Day's Price Range
$0.36
$0.31
9.68%
Downside
16.13%
Upside
52 Week's Low
52 Week's High
52-Week Price Range
$0.31
100.00%
Downside
-100.00%
Upside

Lakewood-Amedex Biotherapeutics Inc. share price movements today

Previous Close: $0.49
Open: $0.34
Volume: 3.9M
Market Cap: $734.6K
Day's Low - High: $0.28 - $0.36

Lakewood-Amedex Biotherapeutics Inc. Historical Returns

1 Month Return: -81.44 %
3 Month Return: -88.26 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Lakewood-Amedex Biotherapeutics Inc. Stock Fundamentals & Key Indicators

Check Lakewood-Amedex Biotherapeutics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$734.6K

EPS (TTM)

-10.02

Dividend Yield

0.00%

PE Ratio (TTM)

-0.03

Industry PE ratio

-3.10

PEG Ratio

0.00

Return On Equity TTM

1687.68%

Lakewood-Amedex Biotherapeutics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Lakewood-Amedex Biotherapeutics Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Lakewood-Amedex Biotherapeutics Inc.	NA	$734.6K	NA	-0.03	0.00%	0.00%
Moderna	Neutral	$79.9B	-42.12%	-25.08	-12.57%	0.00%
BeOne Medicines	StrongBuy	$43.0B	NA	27.86	87.82%	0.00%
Vertex Pharmaceuticals	StrongBuy	$132.8B	184.64%	30.25	86.04%	0.00%
Regeneron	Buy	$82.9B	35.95%	19.22	84.86%	0.46%

Indian Investors' Interest in Lakewood-Amedex Biotherapeutics Inc. Stock

Search interest for Lakewood-Amedex Biotherapeutics Inc. Stock has increased by 6% in the last 30 days, reflecting an upward trend in search activity.

Time period: September 26, 2026 to October 26, 2026

Change:6% versus previous 30 day period

Lakewood-Amedex Biotherapeutics Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Revenue	-	-	-	-
Gross Profit	-	0	-	-
Operating Income	-1	0	0	-3
EBITDA	-1	0	0	-3
Interest Expense	0	0	0	0
Depreciation	0	0	0	0
Income Before Tax	-1	0	0	-3
Income Tax Expense	-	-	-	-
Net Income	-1	0	0	-3
Net Profit Margin	0.00%	0.00%	0.00%	0.00%

Lakewood-Amedex Biotherapeutics Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2025
Total Revenue	-
Gross Profit	-
Operating Income	-3
EBITDA	-3
Interest Expense	0
Depreciation	0
Income Before Tax	-3
Income Tax Expense	-
Net Income	-3
Net Profit Margin	0.00%

Lakewood-Amedex Biotherapeutics Inc. Quarterly Cash Flow

All numbers in Millions USD

	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Net Income	-1	0	0	-3
Operating Cash Flow	0	0	0	-2
Investing Cash Flow	-	-	-	-2
Financing Cash Flow	-	-	0	6
Change in Cash	0	0	0	2

Lakewood-Amedex Biotherapeutics Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2025
Net Income	-3
Operating Cash Flow	-1
Investing Cash Flow	-
Financing Cash Flow	1
Change in Cash	0

Global Institutional Holdings in Lakewood-Amedex Biotherapeutics Inc.

Check out the Institutions with significant holdings in Lakewood-Amedex Biotherapeutics Inc..

Funds	Holdings
Marex Group Ltd	2.03%
HRT FINANCIAL LLC	1.89%
UBS Group AG	0.17%
Tower Research Capital LLC	0.03%
Advisor Group Holdings, Inc.	0.01%

See all

Insights on Lakewood-Amedex Biotherapeutics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NEGATIVE IMPACT
Price Dip
In the last 7 days, LABT stock has moved down by -46.9%

About Lakewood-Amedex Biotherapeutics Inc.

Lakewood-Amedex Biotherapeutics, Inc. operates as a clinical-stage biotechnology company that develops antimicrobial products in the United States. The company offers products from its Bisphosphocin class, a novel class of antimicrobial agents a broad range of infections, including those affecting the skin, bladder, and lungs. It also develops Nu-3, a topical antimicrobial for infected diabetic foot ulcers, which is in Phase 2b clinical trial. The company was formerly known as Lakewood-Amedex Inc. and changed its name to Lakewood-Amedex Biotherapeutics, Inc. in June 2025. Lakewood-Amedex Biotherapeutics, Inc. was incorporated in 2006 and is headquartered in University Park, Florida.

Organisation	Lakewood-Amedex Biotherapeutics Inc.
Headquarters	8031 Cooper Creek Blvd., Unit 103, University Park, FL, 34201, US
Industry	Biotechnology
CEO	Kelvin Cooper

Key Management of Lakewood-Amedex Biotherapeutics Inc.

Name	Title
Daniel Kontoh-Boateng	Investor Relations
Dr. Kelvin Cooper Ph.D.	CEO, SVP of Research & Development and Director
Mr. Peter F. Ceccacci	CFO & VP of Administration
Dr. Thomas Balzer M.D., Ph.D.	Chief Medical Officer & SVP of Clinical Development
Ms. Tara Endress	Project Manager & Accounting Manager

FAQs

What is Lakewood-Amedex Biotherapeutics Inc. share price today?

Lakewood-Amedex Biotherapeutics Inc. share price today is $0.31 as on October 26, 2026 at 8:46 am IST at the close of the market. Lakewood-Amedex Biotherapeutics Inc. share today touched a day high of $0.36 and a low of $0.28.

What is the 52 week high and 52 week low for Lakewood-Amedex Biotherapeutics Inc. share?

Lakewood-Amedex Biotherapeutics Inc. share touched a 52 week high of $0.00 on January 1, 1970 and a 52 week low of $0.00 on January 1, 1970. Lakewood-Amedex Biotherapeutics Inc. stock price today i.e. October 26, 2026 at 8:46 am IST is closed at $0.31,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Lakewood-Amedex Biotherapeutics Inc.'s market capitalisation today?

Lakewood-Amedex Biotherapeutics Inc. market capitalisation is $0.00T as on October 26, 2026 at 8:46 am IST.

How to invest in Lakewood-Amedex Biotherapeutics Inc. Stock (LABT) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Lakewood-Amedex Biotherapeutics Inc. on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Lakewood-Amedex Biotherapeutics Inc. Stock (LABT) from India?

Indian investors can start investing in Lakewood-Amedex Biotherapeutics Inc. (LABT) shares with as little as ₹94.94000244140625 or $1 (as of October 26, 2026 at 9:41 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹949.40 in Lakewood-Amedex Biotherapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on October 26, 2026 at 9:41 am IST). Based on Lakewood-Amedex Biotherapeutics Inc. share’s latest price of $0.31 as on October 26, 2026 at 8:46 am IST, you will get 32.2581 shares of Lakewood-Amedex Biotherapeutics Inc.. Learn more about fractional shares .